1/82
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
Benign Tumors
Well differentiated
Slow-growing
Smaller (usually)
Encapsulated
Non-invasive
Non-metastastic
Suffix: "oma" (example: fibroma)
Malignant Tumors
Poorly differentiated
Fast-growing
Larger
Non-encapsulated
Invasive
Metastatic
Suffix: "carcinoma" or "sarcoma"
Circulating tumor markers
chemicals produced and released by tumors that can be measured in the blood, urine, stool, and other body fluids
Tumor tissue markers
identified directly after collecting the tumor cells. A sample of the tumor is extracted during a biopsy procedure (or the whole tumor is removed) and the tissue is tested for the presence of various markers associated with a type of cancer.
Prostatic acid phosphatase (ACP)
Elevated serum levels can be seen in patients with a carcinoma that has extended beyond the prostatic capsule. This marker is no longer frequently used as a marker as it has been replaced by another tumor marker, prostate specific antigen (PSA).
Alkaline phosphatase (ALP)
used with other tests in diagnosing bone and liver malignancies. Increased levels of this enzyme is often associated with the presence of tumors in the bone or liver tissue.
Creatine kinase, BB isoenzyme (CK-BB)
has been associated with malignancies of several tissues including the lung, prostate, breast, ovary, kidney, bladder, and brain. It is primarily used to monitor a tumor once the tumor is shown to produce the enzyme.
Neuron specific enolase (NSE)
found in tumors of neurologic origin. Ninety percent of children with neuroblastoma have increased levels that correlate well with disease progression.
Human chorionic gonadotropin (hCG)
The placenta, a trophoblastic tissue, naturally secretes HCG. HCG levels are used extensively as a tumor marker. It is elevated in a high percentage of trophoblastic and testicular tumors.
Calcitonin
Elevated levels can be seen in medullary thyroid cancer.
Alpha-fetoprotein (AFP)
Increased levels after birth have been associated with germ cell tumors and hepatoma (liver cancer). This marker often rises before other tumor markers in the recurrence of cancer. It is also a reasonably good marker for primary hepatoma because it is elevated in 80% of cases.
Carcinoembryonic antigen (CEA)
Some malignancies that produce elevated levels include colon, breast, gastrointestinal, lung, ovarian, pancreatic, and prostatic cancer. Certain non-malignant conditions may also cause increased production including alcoholism, bowel inflammation, cystic fibrosis, and heavy cigarette smokers. has been proven useful in determining prognosis and monitoring diagnosed patients and may be measured in blood and other body fluids using immunochemical methods.
Prostate specific antigen (PSA)
It is found in small amounts in the normal prostate and elevated in benign prostate hypertrophy (BPH) and adenocarcinoma of the prostate. Elevated levels may not appear until the disease has advanced. It is no longer used as a standard screening test for prostate cancer.
Carbohydrate Antigen 15-3 (CA 15-3)
commonly found on breast tumor cells. is frequently used to monitor therapeutic response and recurrence to breast cancer.
Carbohydrate Antigen 19-9 (CA 19-9)
This marker is used to follow patients' progress with pancreatic, colorectal, lung, and gastric carcinomas
Carbohydrate Antigen 125 (CA 125)
tumor cell antigen that is used as a marker for ovarian and endometrial cancer. Elevated levels of CA 125 have also been described in pregnancy, endometriosis, and other uterine diseases. The highest levels are seen in ovarian cancer
Cell Membrane Receptors
some breast cancer tumor cells have receptors for the hormones estrogen and progesterone and depend on them to grow. The presence and number of cell membrane receptors may determine the degree of responsiveness of certain types of tumors to therapy
Tumor suppressor genes
genes that encode proteins that are involved in controlling unregulated growth. If these genes are mutated, it will likely lead to the formation of a tumor.
Oncogenes
transform normal cells into tumor cells
minimum effective concentration (MEC)
the lowest concentration of drug in the blood that produces the desired response
Minimum toxic concentration (MTC)
the lowest concentration in the blood that will produce an adverse response
trough drug level
the lowest concentration of the drug measured in blood after the patient has achieved a steady state. trough levels should normally be reached immediately before the next dose of drug and should not fall below the MEC
peak level
represents the highest concentration of drug measured in blood. should not be higher than the MTC.
absorption
the process of a substance entering the blood circulation
drugs that are administered by oral, rectal, or sublingual routes are usually absorbed in the GI tract.
distribution
the dispersion of the drug throughout the fluids and tissues of the body
metabolism / biotransformation
breakdown of the drug from parent compounds into daughter metabolites
The major site of drug metabolism is the liver
Most drugs are metabolized by first-order kinetics
excretion / elimination
the removal of the drug from the body
first-pass effect
the drug on first pass through the liver is substantially metabolized even before reaching the systemic circulation.
For some drugs that undergo first pass effects, the blood concentration of the active drug is decreased because of production of inactive metabolites.
Other drugs may be metabolized to compounds that themselves have pharmacological activity, causing an increased therapeutic effect in patients.
First-pass effects of a drug must be taken into consideration when determining the dose.
Pharmacokinetic
the study of movement of a drug into, through, and out of the body and therefore it measures rates of absorption, distribution, biotransformation and excretion
Metabolic clearance (CL)
is the sum of all processes by which a drug is cleared from the body per unit time.
CL= rate of elimination/concentration
Volume of distribution (Vd)
is the distribution characteristics of a drug.
Vd= dose/concentration in plasma
Drug Half-Life
the time required for the concentration of a drug to be decreased by one half
t1/2= 0.693 Vd/CL
Digoxin and Digitoxin
function to increase the force of the heart's contraction while decreasing its rate to slow and strengthen the contraction.
Peak levels are usually evaluated 8 hrs after an oral dose. At this time, the serum levels are thought to correlate well with tissue concentrations.
Levels are usually measured with immunoassays
Antiarrhythmic Drugs
lidocaine, quinidine, procainamide, disopyramide
measured using immunoassays, GC, or HPLC
Phenobarbital
Used to treat all seizures except petit mal seizures
Has a long half-life - peak levels should not be drawn before 8-10 hrs have passed
Phenytoin (Dilantin)
Most widely prescribed and is also an antiarrhythmic
Toxic levels cause seizures
Has variable half-life and does not follow first order kinetics
Valproic acid
Has a long half-life
Used to treat most types of seizures often in combination with phenobarbital and phenytoin
Primidone
Metabolized to phenobarbital so phenobarbital must be measured along with it
Carbamazepine (Tegretol)
Generally only used for folks who do not respond to other drugs in this category
Highly protein-bound
Ethosuximide
Only used for petit mal seizures
Theophylline
CNS, respiratory, and cardiac stimulant
Causes smooth muscle relaxation and diuresis
Aminoglycoside Antibiotics
amikacin, streptomycin, gentamicin, kanamycin, tobramycin, neomycin
Used to treat gram-negative aerobic bacteria
Chloramphenicol
Used for gram-negative infections although not frequently prescribed anymore
Vancomycin
Used for gram-positive cocci infections
Trough levels usually monitored
Tricyclic antidepressants (TCA)
Widely used class that includes imipramine, desipramine, amitriptyline, nortriptyline and doxepin
Usually only monitored initially
Lithium
Used for treating bipolar disorders
Ion selective electrode (ISE) measurements are used most often to monitor levels
Cyclosporine
Used to suppress the immune system after transplantation
Current methods for measuring include: immunoassays and HPLC-MS
Tacrolimus (FK-506)
More potent than cyclosporine – smaller dosage
Methotrexate
Interferes with cell metabolism inhibiting cell replication.
Half-life is quite variable so dosage must be adjusted for the individual.
Cisplatin and cyclophosphamide
Alkylating agents that prevent DNA from undergoing replication
Classes of Toxic Substances
Gases - gaseous substances inhaled by the subject Example: carbon monoxide
Alcohols (Volatiles) - volatile liquids usually ingested by the subject Example: ethyl alcohol (ethanol)
Heavy metals - metals which remain in tissues and accumluate over time Example: lead
Nonvolatiles - other toxins such as pesticides, drugs of abuse, and therapeutic drugs in overdose
Carbon Monoxide (CO)
An odorless, tasteless gas normally present in small amounts in the atmosphere. Produces hypoxia in brain and heart
Hemoglobin has an affinity for CO as a level 200x greater than that for oxygen. Hemoglobin will preferentially bind CO (in lieu of oxygen). This may lead to reduced oxygen delivery, hypoxia, and anoxia in affected individuals
Whole blood is required for testing
Gas-liquid chromatography is the reference method
Cyanide
Very powerful toxin with many exposure routes (ingestion, inhalation, or absorption). Used in insecticide and rodenticide products
Binds to iron in the cytochrome oxidase complex (electron transport chain) in mitochondria and inhibits cellular production of ATP.
Although there is plenty of oxygen available, the cell cannot make ATP
Ethanol (EtOH)
The liver metabolizes most of the alcohol although a small amount is excreted unchanged through the lungs and kidneys. Alcohol dehydrogenase (ADH) converts EtOH first to acetaldehyde and then to acetic acid, which is capable of entering the TCA cycle
Since alcohol levels may be introduced as evidence in court cases, "chain of custody" must be appropriately documented in these potential cases.
Methanol (wood alcohol)
Used as a topical disinfectant
Metabolism - Methanol is converted to formaldehyde, which is metabolized to formic acid
Propanol (isopropanol)
Used as a topical disinfectant
Metabolism - Propanol is converted to acetone
Ethylene Glycol
Common ingredient of antifreeze
Metabolism - ethylene glycol is converted to glycolic acid and then oxalic acid.
An increased anion gap is characteristic of ethylene glycol poisoning.
Calcium oxalate crystals may also be seen in the urine
Lead
binds to proteins and inhibits (noncompetitive inhibition) many enzymes:
Inhibits heme synthesis pathway
Enzymes inhibited : delta aminolevulinic acid dehydrogenase and ferrochetalase
Results in decreased hemoglobin production
Pesticides
They act by interfering with the action of acetylcholinesterase at neuromuscular junctions and nerve endings.
Measurement
Erythrocyte acetylcholinesterase levels
Serum Pseudocholinesterase is often performed because acetylcholinesterase is difficult to measure.
Decreased levels are seen with pesticide poisoning
Amphetamines (stimulants)
include drugs such as pseudoephedrine, ephedrine, and phentermine.
Used to treat narcolepsy and disorders affecting the ability to focus. Also used to provide a sense of mental and physical well-being
Anabolic steroids
Function: Used to increase muscle mass and athletic performance
Analysis: Gas or liquid chromatograph
Cannabinoids
provide a feeling of mental well-being and euphoria but impair function and short-term memory.
Common substances in this group are marijuana, hashish, sensimilla, pot, and THC
has a relatively long half-life (7-8 days) and accumulates in lipid tissues within the body. – Detectable levels may be evident 1-4 weeks after use
Cocaine
Used as a topical anesthetic for nasal surgery; however, it is most often taken illegally for its stimulant effects
metabolized so quickly it is rare to see the parent compound in the blood or urine of the patient by the time he/she reaches the emergency department.
Hallucinogens
Phencyclidine (PCP): Used as an anesthetic. Has CNS stimulant, depressant, and hallucinogenic properties. Low doses lead to a sense of euphoria. High doses may cause a sense of superhuman strength followed by coma and death.
Lysergic acid diethylamide (LSD: Produces perceptual distortions and rapid emotional changes including panic attacks and hallucinations
Methylenedioxymethamphetamine (MDMA): Probably best known by the street name "ecstasy". Produces feelings of euphoria and heightened sexuality. Can be extremely dangerous in high doses
Opiates
Used as analgesics, sedatives, or anesthetics. Mainly used to relieve pain in moderate doses. Abuse may lead to CNS depression
Naturally occurring: Opium, morphine, codeine
Chemically modified: Heroin, dilaudid, oxycodone
Synthetic: Demerol, methadone, darvon, talwin, fentanyl
Tricyclic antidepressants
include a large number of prescription drugs.
Function: Used to treat depression, migraine, chronic pain and eating disorders.
Toxicity may lead to cardiac arrest.
Tranquilizers
sedative hypnotics that produce depression of CNS, Respiratory depression causes respiratory acidosis
Barbiturates: This group of drugs includes phenobarbital (long-acting), amobarbital (intermediate-acting), secobarbital (short-acting). These drugs are sedatives, depressants, or tranquilizers
Benzodiazepines: to reduce anxiety, treat sleep disorders and seizures. Examples: chlordiazepoxide (Librium), diazepam (Valium), lorazepam (Ativan)
Salicylates (aspirin)
Used as an analgesic (pain relief), antipyretic (fever reducing), and anti-inflammatory
Toxicity initially causes respiratory alkalosis (respiratory center stimulant). This is followed by metabolic acidosis as metabolites are formed
Ferric nitrate method (spectrophotometric)
Acetaminophen (tylenol)
Used as an analgesic
Overdoses will lead to hepatotoxicity due to intermediate metabolite accumulation in the liver.
In-vitro diagnostic clinical research studies
Use human tissues and/or fluids to study disease to contribute to the general body of knowledge of the associated disease
The analysis is not directly linked to any living individual
Patient-oriented research (POR) studies
Used to study mechanisms of disease, therapies, or to develop new technologies related to a disease
Investigator directly interacts with subjects
Reliability
The overall consistency of a measure. A measure is said to have a high reliability if it produces similar results under consistent conditions.
Validity
The degree to which a data instrument measures what it is supposed to measure. The measurement does not always have to be similar, as it does in reliability. However, just because a measure is reliable, it is not necessarily valid (and vice versa).
Generalizability
The extent to which the findings of a clinical trial can be reliably extrapolated from the subjects who participated in the trial to a broader patient population and a broader range of clinical settings.
Observational Studies
Involve humans (cohort or epidemiological studies) but do not specifically tie information to individual patients
Mechanistic Studies
Used to investigate causality
Usually small-population based studies - therefore the results may not be generalizable to a larger population
Therapeutic Studies
Used to determine the efficacy of a medicine or a treatment which is designed to improve a condition or disease.
Smaller and less definitive than large-scale clinical trials
Large-Scale Clinical Trials
Clinical trials conducted over an extended period of time with a large subject pool
Meta-Analysis
Process in which the results of multiple individual studies are statistically combined and analyzed
Formal evaluation of the evidence from two or more trials focused on answering the same question
Translational Research
"Bench to bedside" was formerly used to describe this process; however, translational research is not unidirectional. Once a biological premise or tool is adapted to a medical setting, clinical data derived from patients may inform both patient-oriented and basic investigation
General Sequence of a Clinical Study
Observation
Generation of a testable hypothesis
Design of a study that will test this hypothesis
Performance of the study (hypothesis testing)
Collection of data from the study
Data analysis and interpretation
Formulation of conclusions
B-glucuronidase tumor marker
cancer of urinary bladder
leucine amino peptidase (LAP)
liver cell carcinoma